Aerobic Exercise Improves Cognition for Older Adults with Glucose Intolerance, a Risk Factor for Alzheimer's Disease
Overview
Neurology
Authors
Affiliations
Impaired glucose regulation is a defining characteristic of type 2 diabetes mellitus (T2DM) pathology and has been linked to increased risk of cognitive impairment and dementia. Although the benefits of aerobic exercise for physical health are well-documented, exercise effects on cognition have not been examined for older adults with poor glucose regulation associated with prediabetes and early T2DM. Using a randomized controlled design, twenty-eight adults (57-83 y old) meeting 2-h tolerance test criteria for glucose intolerance completed 6 months of aerobic exercise or stretching, which served as the control. The primary cognitive outcomes included measures of executive function (Trails B, Task Switching, Stroop, Self-ordered Pointing Test, and Verbal Fluency). Other outcomes included memory performance (Story Recall, List Learning), measures of cardiorespiratory fitness obtained via maximal-graded exercise treadmill test, glucose disposal during hyperinsulinemic-euglycemic clamp, body fat, and fasting plasma levels of insulin, cortisol, brain-derived neurotrophic factor, insulin-like growth factor-1, amyloid-β (Aβ40 and Aβ42). Six months of aerobic exercise improved executive function (MANCOVA, p=0.04), cardiorespiratory fitness (MANOVA, p=0.03), and insulin sensitivity (p=0.05). Across all subjects, 6-month changes in cardiorespiratory fitness and insulin sensitivity were positively correlated (p=0.01). For Aβ42, plasma levels tended to decrease for the aerobic group relative to controls (p=0.07). The results of our study using rigorous controlled methodology suggest a cognition-enhancing effect of aerobic exercise for older glucose intolerant adults. Although replication in a larger sample is needed, our findings potentially have important therapeutic implications for a growing number of adults at increased risk of cognitive decline.
Cakaloglu E, Yuksel H, Sahin F, Guler O, Arslanoglu E, Yamak B Life (Basel). 2025; 15(2).
PMID: 40003639 PMC: 11856442. DOI: 10.3390/life15020230.
Guo J, Liu J, Zhu R, Liu G, Zheng M, Cao C Behav Sci (Basel). 2025; 14(12.
PMID: 39767367 PMC: 11673064. DOI: 10.3390/bs14121227.
Amyloid-beta metabolism in age-related neurocardiovascular diseases.
Aivalioti E, Georgiopoulos G, Tual-Chalot S, Bampatsias D, Delialis D, Sopova K Eur Heart J. 2024; 46(3):250-272.
PMID: 39527015 PMC: 11735085. DOI: 10.1093/eurheartj/ehae655.
Yang K, Yang X, Yin P, Zhou M, Tang Y Alzheimers Dement. 2024; 20(11):7871-7884.
PMID: 39312279 PMC: 11567818. DOI: 10.1002/alz.14254.
Kugler B, Lysaker C, Franczak E, Hauger B, Csikos V, Stopperan J Geroscience. 2024; 46(5):4955-4967.
PMID: 38867031 PMC: 11336007. DOI: 10.1007/s11357-024-01248-3.